Article Details

Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting ...

Retrieved on: 2022-10-05 08:02:07

Tags for this article:

Click the tags to see associated articles and topics

Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting .... View article details on hiswai:

Excerpt

Details: Category: Antibodies: Published on Wednesday, 05 October 2022 09:58 ... its best-in-class, humanized monoclonal antibody targeting MASP2, ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up